Pipeline

•CB-101, a first-in-class trispecific TCE for colorectal, pancreatic, lung cancers 

•CB-201, a best-in-class costimulatory trispecific TCE for breast, ovarian cancers 

•CB-301, A trispecific TCE for hematologic malignancies or autoimmune diseases Text